Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41586-023-06696-z
PubMed Identifier: 37844613
Publication URI: http://europepmc.org/abstract/MED/37844613
Type: Journal Article/Review
Volume: 623
Parent Publication: Nature
Issue: 7989
ISSN: 0028-0836